NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment
October 25, 2022 08:00 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
October 12, 2022 12:27 ET
|
UsAgainstAlzheimer's
Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical...
With 7.4% CAGR, Dermatophytic Onychomycosis Treatment Market Size worth USD 6.63 Billion in 2027
September 14, 2022 06:55 ET
|
Fortune Business Insights
Pune, India, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The global dermatophytic onychomycosis treatment market size is predicted to reach USD 6.63 billion by 2027, exhibiting a CAGR of 7.4% during the...
Autoinjectors Market Size is projected to reach USD 4.61 Billion by 2030, growing at a CAGR of 18.23%: Straits Research
August 10, 2022 12:20 ET
|
Straits Research
New York, United States, Aug. 10, 2022 (GLOBE NEWSWIRE) -- An autoinjector is a prefilled syringe with a spring-loaded needle that automatically inserts the needle at the right injection location....
Radioligand Therapy Market Size is projected to reach USD 15.84 Billion by 2030, growing at a CAGR of 4.62%: Straits Research
August 01, 2022 12:30 ET
|
Straits Research
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Radioligand Therapy is a revolutionary way of treating cancer. It targets cancer cells precisely and minimizes damage to healthy cells,...
Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle
July 18, 2022 11:57 ET
|
Citrine Global, Corp.
Tel Aviv, July 18, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent...
Successful Treatment for Large Osteochondral Lesions of the Talus
July 11, 2022 14:03 ET
|
American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., July 11, 2022 (GLOBE NEWSWIRE) -- According to a new study published in Foot & Ankle International (FAI), patients suffering from large Osteochondral Lesions of the Talus (OLTs)...
Industry Leaders Welcome New Study of Save Foods’ Treatment Showing Extended Shelf-Life of Mangos While Virtually Eliminating Post-Harvest Pesticides
June 21, 2022 08:30 ET
|
Save Foods Inc
Following the mango study results, Galilee Export, Israel’s second-largest fresh produce exporter, plans to use Save Foods’ solution for its mangos in the upcoming 2022-2023 season Miami, FL,...
Update on Positive Pre-Clinical Results from AIM Biologicals Development Program for the Potential Treatment of Parkinson’s Disease
May 12, 2022 08:05 ET
|
Aeterna Zentaris Inc
– Data presented at IMMUNOLOGY2022™, the Annual Event of the American Association of Immunologists – Company advancing development of its Autoimmunity Modifying (“AIM”) Biologicals as a potential...
CLINUVEL progresses vitiligo treatment program
May 09, 2022 21:33 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America this year. The drug afamelanotide...